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SUMMARY
This longaudinal study was ongmally designcd lo dctect changes in thc m utio immune response of
healthy subjccts as a lesult of a psychological Intervention In this study a sigmficant piopoition
aboul 70%, of the immunological vai labihty in the test results was atcounted for by the differences in
immunological lesponsc levcls of thc subjccts Apait fiom this bctwccn-subjcct-effcct, a sigmficant
Proportion of the vanability in test icsults was related to thc month of data samphng The month
effect was computed in such a way that thc betwecn subject vanation was taken into account This
rcsuited ina moie accurate estimation of the monlh-effecl Even aftcrcoirecüon foi theintei vcntion,
ι e the defence ofthe PhD thesis the effect of monlh ot data samphng lemains sigmficant foi mcan
coipusculai hacmoglobin, mcan corpusculai hacmoglobin conccntration, peicentage of CD4 and
CD8 cells, and foi the lesponse to the mitogens phylohaemagglulinin, pokewccd mitogcn and
concanavalm Α as well as the icsults foi the mixcd lymphocyte cultuic for one pool out of thiee In
contrast, no sigmficant month-effect was obscrved for the whole blood cell counts, for thc differenlial
white blood teil counls as deleimincd by monotlonal antibody staining foi ccll sui facc markci s CD 3,
CD 16 TAC and OK.M1, noi foi thc immunoglobuhn IgM and IgG serum levels Likcwise the ccll-
mcdiatcd lympholysis activilies measuied agams! thicc pools ol stimulator cells lcmained unaltcied
We discuss thc implications foi futuic immunological follow-up studies ol thc observation that a
sigmficant piopoition of thc variability in immunological test icsults IS lclatcd to differences betwecn
subjccts and to the month of data samphng
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INTRODUCTION
Thc within-subjcct vanabilily of lest lesults ovci timc is of
pnncipal lntcicsl foi the momtoiing of in ι in ο immunological
paiametcrs in subjeets befoie and aftci chnical oi othci
mteiventions Diflercntiating between exp^nmentally-induccd
Variation and othei sources of variability is essenüal foi thc
inteiprctation of thc results Apait fiom bclwecn-subject vana
bihty, Variation in immunological test lesults has becn attn
buted to technical aspects diuinal vaualion and scasonal
vanation Fest vanation as the result of the use of different
laboiatoiy supphes dunng the penod in which the study is done
is widcly lecognized and easily controlled (Kiecolt-Glaser
1988) Anothci souice of vanation is duc to thc 24 h lhythm of
some immunological activities (Tavadia et al 1975 Κ aplan et
al 1976) Thcicfoie, most studies mimmize the diuinal vana
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tion by keeping the houi of blood samphng quite constant
(Kiccolt-Glasci 1988) \ thud souice of vanalion, and less
easily contiolled lsoftcndcscnbcd as bcingduc tocucannual oi
scasonal ihythms Although thcieissomcevidenccfoi a month
of-data-samphng-effect on diffeient immunological paiameteis
the lesults presented by different authois (Reinbeig et al 1977,
Rocker et al, 1980, Biatescu & Teodorescu, 1981, MacMurray
et al, 1983, Munch-Petersen, Wallevik & Fabei 1985, Williams
et al, 1986, Melmkov et al, 1987, Boctor, Charmy & Cooper
1989) aie cquivotal The numbei of immunological parametcis
studied is often small as is thc numbei of subicets Furthcimoie
thc centics whcie thesc studies aie cained out diffci in then
chmate houisof hght and tempeiatuie Smcctheicsultsseem to
vaiy with climatological conditions, le ovci yeais and ovei
geographical aicas they cannot bc used to computc a gcneiall}
apphcablc concction factor foi thc time-effeet Thcicfore it is
necessaiy to incorpoiate the correction foi month-specific
cfTects into thc statistical anal>sis of thc immunological data
This statistical method is desenbed m this study
Oui longitudinal study was ongmally designcd to deteet
changes in the in utio immune lesponse in ielation lo thc
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Table 1. Number of observations per
month
Month
1
2
3
4
5
6
7
8
9
10
11
12
I
2
17
21
15
18
26
18
12
25
15
21
24
II
0
7
11
7
11
16
10
3
14
8
9
14
Missing
Total
21
235 115
I, Number of observaüons for all
immunological variables except foi cell
mediated lympholysis(CML) II number
of observations for CML
psychological stress of the defence of a PhD thesis In the course
of analysing the data, we noted a strong efFcct on some but not
all in υ\ΐιυ immunological mcasurcs tested It appeared that this
effeet could bc completely explaincd by the month in which the
blood samplcs were gathered Furthermorc, for each immunolo-
gical variable a sigmficant subjeet-effeet was noted As will be
shown, when this between-subjeet-effeet IS taken into aecount a
more rehable estimaüon of the month-effect is obtained
MATERIALS AND METHODS
Immunological assay s
Over a penod of 12 months (February 1986-Januaiy 1987) five
senal blood samples werc collected from 47 PhD students, 41
malcs and six females, with an average age of 35 years (s d 6 3,
ränge 26 58) Since therv are only two obseivations in lanuary
1987 this month was exeluded from further analysis (see Table
1) All samples were collected dunng the same 2-h pci lod in the
morning in order to hmit diurnal vanations
In total, 235 (47 χ 5) observations per immunological assay
wcie planned Missing observations due to techmcal eirois or
missmg blood samples wcie always less than 25 As an
cxcepüon, for the cell-mcdiatcd lympholysis (CMI ) the rcsults
of only 21 subjeets were available for statistical analysis (Table
1)
Blood samples
At each samplmg point, 40 ml of hepannized blood (for the
cellular assays), 4 ml of blood anti-coagulated with ethylenedia-
minetctraacetic acid (for whole blood cell counts), and 10 ml
blood without addition of anti-coagulant (foi sei um samplmg)
were collected
From the hcparmi/ed blood samples, penpheral blood
lymphocytes (PBL) were isolatcd by Ficoll-Isopaquc density
gradientcentnfugation,washedandresuspendedin RPMI 16^0
(Dutch modification), supplemented with 3 mmol// L-gluta-
mine, 50 /(g/ml gentamycin and 15% heat-inactivated pooled
human serum with dimethylsulphoxide (final concentration
10%) for cryopreservation in liquid nitrogen In order to hmit
the laboratory test Variation, all blood samples of a givcn subjeet
were thawed and tested on the same day in the same expenment
The same laboratory supplies were used throughout the whole
study
Human leucocyte antigen typing
All subjeets, as well as the stimulator cells used in the mixed
lymphocyte eulture (MLC) and CML assays, were typed foi
HLA-A, -B and -C antigens with the Standard lymphocytotoxi-
city techmque (van Rood, 1974), typing for HLA-DR anligens
was performed with the two-colour fluorescence lest (van Rood,
van Zceuwen & Ploem, 1976)
Whole blood cell count
Whole blood cell counts and differential white blood cell counts
were analysed by a Coulter counter Information was obtained
on the concentration of haemoglobm (Hb mmol//), number of
erythrocytes (1012//) and the haematoent volumc The mean
corpuscular volume (MCV), mean Hb concentration (MCV),
and mean corpuscular Hb concentration (MCHC) were com-
puted from the above Information Within the population of
leukocytes (109//) the percentage of eosinophils, basophils,
polymorphonuclear cells, neutrophils, lymphocytes and mono-
cytes was assessed Screcnmg was also performed for presence of
(pro)myelocytes, meta and blast cells
Phenotype analysis
The mononuclear cells were staincd by a Standard indirect
immunofluorescence techmque usmg the following monoclonal
antibodics anti-CD3 (OKT3), anti-CD4 (OKT4), anti-CD8
(OKT8), anti-CD16 (Leul 1b and Leu 19), anti-TAC (anti-IL-2
reeeptor) and anti-OKMI (anti-monocytes and -granulocytes)
in the flrst step and goat anti-mouse (GAM) in the second step,
and assayed on a fluorescence activated cell sorter (FACS
analysei, Becton Dickinson, Mountain View, CA)
Sei um levels oj immunoglobuhm IgG and IgM
Separate senal blood samples were taken to measurc IgG and
IgM serum concentrations Serum was assayed foi albumin,
IgG and IgM using a Beckmann array protein System All tests
weie performed aecording to the manufacturer's conditions
(Sternberg, 1977, Salden et al, 1988)
Lymphocyte tiansjormatwn test (LTT)
Penpheral blood lymphocytes were meubated in tissue eulture
medium (RPMI 1640 supplemented with 3 mmol//1 -glutamine,
50 /(g/ml gentamycin and 15% heat-inactivated pooled human
serum) for 2 days in the presence of mitogen phytohacmagglu-
tmin (PHA), pokeweed (PWM) or concanavahn Α (Con A) To
100 μΐ cell Suspension 100 μ\ of the following mitogens were
added PHA (HA-16, Wellcome Diagnostics, Dartford, UK, 2
mg/5 ml) from a 4 //g/ml dilution, PWM (GIBCO, Paisley,
Scotland, cat no 061-05360) from a 1/100 dilution, or Con Α
(Calbiochem Behnng Corp , La Jolla, CA, 234567, 2 5 mg/ml)
from 10 /(g/ml and 40 /ig/ml diluüons The mitogen-induccd
prohferative activity was measured at day 3 aftcr overnight
Month-related vanabüüy in immunological test results
Table 2. Subject effect and month-effect for all immunological variables
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Variable
Haemoglobin
HT
Erythrocytes
MCV
MCH
MCHC
Leukocytes
Eosmophils
Basophils
Neutrophüs
Lymphocytes
Monocytes
CD3
CD4
CD8
CD4/CD8
a-Tac
CD 16
a-monocytes
IgG
IgM
PHA
PWM
Con Α 10
Con Α 40
MLC-1
MLC-2
MLC-3
CML 1
C M L 2
CML-3
Between-
subject vanance
0 3657
6 53 04
0 1257
12 847
0 0068
0 1506
1 0097
2 37-04
0 07 04
0 004
0 003
1 70 0 4
63 095
58 759
46 519
0 4303
19 525
51 487
87 548
2 9378
0 1777
0 0145
0 0198
0 0296
00158
0 0722
0 0537
0 0905
00134
0 0166
0 0176
Subject
Residual
vanance %
0 1094
3 23 04
0 0615
5 5041
0 0017
0 2867
0 8265
2 4-04
0 28 °4
0 0044
0 0043
5 38~04
29 755
34 75
11 838
0 1181
2 9229
22 192
35 471
0 9904
0 0443
0 0095
0 0177
0 0281
0 0172
00152
0 0107
0 0163
0 0061
0 0067
0 0045
vanancef
77
67
67
70
80
35
55
50
20
45
41
24
68
63
80
79
87
70
71
75
80
60
53
51
48
83
83
85
69
71
80
Reduction
factorj
2 1
1 7
1 7
18
22
12 ;
Month
F
07
71
58
82
>96
! 10
15 0 078
1 4
1 1
1 3
1 3
1 2
1 8
16 :
22 ;
22
21
13
70
20
44
78
>77
>82
70
2 8 0 71
1 8
1 9
20
22
16 ;
1 5
1 4
14
2 4
2 5
26
1 9 (
1 9
22
60
57
42
65
2 27
>36
5 10
5 91
5 74
60
28
)66
198
37
Ρ
0 389
0 082
0 117
0 061
0 002*
0 027*
0 645
0 292
0 342
0 087
0 299
0 170
0 069
0 004*
0 003*
0 086
0 716
0 112
0 120
0 178
0 099
0017*
0 013*
0 001*
0 000*
0 000*
0 113
0 245
0 760
0 466
0 209
* Significant
t Relative between subject-cflect
HT, Hacmatocrit volume, MCV, mean corpuscular volume, MCH, mean corpuscular
haemoglobin, MCHC, mean corpustular haemoglobm concentration, PHA, phytohaemag-
glutinin, PWM, pokeweed mitogen, Con A, concanavahn A, MLC, mixed lymphocyte cultuie,
CML, cell-mediated lympholysis
labelling of the cultures with 1 H-thymidinc The logio of the
counts was takcn in ordci to reduce the effect of extremely high
counts
Cell-mediated lympholysis
Allogeneic cytotoxic effector cclls were geneiated in small
cultuie flasks through coculturc of 8 χ 106 PBL as responder
cells with 8x 106 30 Gy-nradiated Simulator cclls in 16 ml
culture medium The sümuldtoi cells were denved fiom three
different pools of lymphocytes each consisting of mononuclear
cell preparation» from three healthy individuals cairymg differ-
ent HLA antigens The respondei/stimulatorcel! combmations
were cultured for 6 days and thereaftei tested against the three
stimuiator cell pools as target cells Cytotoxicity was measured
using the Standard CML assay (Goulmy, 1982) Bnefly, 5x10 '
51Cr-labelled Τ lymphoblasts, generated by treatment of PBL
with 1% PHA mitogen (DIFCO Laboratories, Detroit, MI) for
3 days and expanded in IL-2, weie ineubated at 37 C for 4 h
together with 2xlO 5 , 1 χ 105 and O5xlO 5 effector cells
(Ε Τ = 40 1, 20 1 and 10 1) The supernatants were then
harvested for counting in a gamma counter (Packard Instru-
ments, Downers Grove, USA) The percentage of specific 5 iCr-
release was calculated aecording to the following formula
cxpcnmcntdl lelease —spontaneous iclease . .
maximal release —spontaneous releasc
Mixed lymphocyte eultut e
Pnmary cultures were estabhshed in round-bottomed microtitre
plates Responder cclls (105) were ineubated for 5 days with 105
irradiated (30 Gy) stimuiator cells denved from three different
pools of lymphocytes, each consisting of mononuclear cell
preparations from three healthy individuals carrying different
HLA antigens Sixteen hours befoie harvesting, the cultures
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were labellcd with 1 μ θ Ή-thymidine Isotope incorporation
was measured in a liquid scmtillaüon counter Expenmental
values are computed as the log,0 of the median of the results of
the tnphcate cultures expressed in counts per mm (ct/mm)
Stalistical analysis
In order to correct for the inbdiance due to unequal distnbution
of the datd over the months and to take into aecount the
between-subjeet Variation, the immunological data were ana-
lysed using (SPSS-X) MANOVA, multivanate analysis of vanance,
with a two-way factonal, subjeet χ month, design with 47
subjeet and 11 month categones
Our data can be desenbed as x, = μ + α. + β, + e
m
 in which χ is
the raw score for subjeet / at timey, μ is the group mean, σ is the
between-subject-efTect, β is the month-specihc-effect and e
the lesidual (error) The between-subjeet vanance (a2
subj) is the
vanance of the a,'s and the residual vanance (a2rmiä) is the
vanance of the e,/s Analysis of vanance is used for two
purposes, firstly to test for d month-effect and secondly to
estimate the two vanance components between-subjeet and
residual vanance, respectively (To be complete we also per-
formed a formal sigmficance test for the presence of between-
subjeet vanance ) These vanance components can be estimated
by classical methods as desenbed by Fleiss (1986) Having
computed the two vanance components, two related quantities
are of interest Firstly, the percentage of the total vanance that is
due to the between-subjeet Variation (100 χ (a2,
ubJ(a\llbs + σ2κ
s d)) and secondly the reducüon factor by which the Standard
error of the estimated month-effect is reduced when the subjeet
effect is corrected for This reduction factor apphes when
companng the effects for differenl months Moreover, to check
thdt the estimdte of the month effect wds not dffected by the
Intervention, two tests on the intervention-effects were carried
out by the MANOVA with sequential subjeet Intervention and
month-effect, where the Intervention was assumed to have effect
either 2 weeks before or 2 weeks after (test 1) or 1 month before
or 1 month after (test 2) the defence of the PhD thesis
Furthermore, an example is given of the misleading effect of
deleting the subjeet-effeet in the analysis and the ments of our
dlternative approach in which the between-subjeet effeel is taken
into aecount
RESULTS
Reduction of the Standard enoi of momh-effects by taking into
auoimt the between-subjeet vanability
The vanance components and related quantities arc given in
fable 2 All between subjeet vanances were highly significant
(Ρ<Ό001 for all variables considered) From Tablc 2 lt is
apparent that the relative subjeet vanance is >707> for 16ofthe
vanables studied This is cquivalent to a reduction factoi > 1 8
for the standdrd error of the estimdted month effect To
lllustratc the effect we hdve presented some detailed results foi
CD8 In Fig la the rnean peicentdge of CD8 cells per month
and the Standard errors are given and in Fig lb the estimated
month-effect after correction for the subjeet-effeet and the
corresponding Standard errors are given The Standard erroi s in
Fig lb are about twice as small ds in Γ ig la which is in
aecordance with the reduction factor given in Fable 2
All results presented below are corrected for the between
subjeet effect as desenbed above
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Fig 1 (a) The mcan percentdge of CD8 cells per month ( + s, e ) The
Standard errors of the monthly averages are uncorrected for the
belwcui subjeet vanance (b) Percentdge of CDS cells pei month
( ± s e ) Thc icsults arc cxpiessed as the difiercnccs per month fiom the
ovcrdll mean percenlagc of CD8 cells Thc conespondmg stand ud
eirors of thc cstimatcd month efieet arc corrected for thc between
subjeet vanance
Intervention effect
Since the Intervention (ι e the stress of the defence of a PhD
thesis) could mflucnce the results on the month-effects, lts effect
was established with MANOVA NO Intervention effect was
observed for Intervention tests 1 and 2 (see Mdtenals and
Methods) (data not shown) The observed month-effects could
not therefore be the result of thc Intervention
Month-ejjec ts on cellular and serological immunological measut e
ments
Multivariate analyses of vanance of the red and white blood cell
counts revealed significant month-of-data-samplmg-cffects for
the MCH ( F = 2 96, />=0 002, df= 10,119) and the MCHC
(/"= 2 10, Ρ = 0 027, df = 10,119) (Tablc 2) The month-effect for
MCH was found in February, March and October and for
MCHC in February and October (Table 3)
Multivanate analyses of vanance of the results of phenotype
analyses revealed a significant month-effect for the percentage
of CD4 ( F = 2 77, /> = 0 004, df= 10,145) and CD8 cells
( F = 2 82, Ρ = 0 003, df= 10,145), but not for thc CD4/CD8
ratio, the percentage ofCD3 Leull and Leu 19 (CD 16) cells and
foi the percentage of cells staining with the anti-TAC mono
clonal antibody (Tablc 2) The month-effect was found foi CD4
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1 able 3. Mean, Standard error and diflerences from the mean per month for the nnmunologicdl variables for which a
significant month-efTect was observed
Month
2
3
4
5
6
7
8
9
10
11
12
S 0
MCH
1 842
0 023*
-0 028*
-0010
-0 002
-0 002
-0 009
-0015
-0 008
0031*
0017
0 003
0 008 0 012
MCI IC
20 520
0 286*
-0 038
-0 221
-0 202
-0 137
-0 035
0 270
-0 209
0 330*
0 098
-0 142
0 110-0 160
CD4
55 108
-2 548
-1 853
-1 344
-3 316*
-0 097
-1 490
1 132
0 633
3 090*
5 400*
0 396
1 21 1 76
CD8
Mean
33 275
-4 400*
-0213
1 424
0 616
-0 534
-0912
0 730
0 530
1 966*
0 549
0 243
0 740 1 03
PHA
5 100
-0 007
0 023
-0 080*
-0 003
0 010
0 004
-0017
-0 031
0015
0 078*
0 007
0 020 0 029
PWM
4 394
-0 054
0017
-0 003
-0 032
-0 009
-0 056
-0 045
-0 025
0081*
0 112*
0012
0 027 0 040
Con Α 10
4 234
-0017
0 032
-0 059
-0 029
0 006
-0 024
-0 141*
-0 048
0 046
0 165*
0 070*
0 035 0 048
Con Α 40
4 632
-0015
0 008
-0 080*
-0 027
0 008
-0 042
-0 091*
-0 032
0 061
0 143*
0 067*
0 027 0 041
* Significant
Valucs aic diflerences fiom the overall mean
s c , Range of Standard eiroi, MCII mean corpuscular hacmoglobin, MCHC mean corpuscular haemoglobin
concentration, PHA phytohaemagglutinin, PWM pokeweed mitogen, Con A, concanavalin Α
in May, Octobei and Novembct and ioi CD8 in Febiuaiy and
Oetobei (Tablc 3)
hoi the scium coneenttations of immunoglobulins IgG and
IgM no significanl month-effeet was obscivcd (lable 2)
Month-effects on funitwnal immunological in vitio studwi
All mitogenic lesponses tested in oui study had a significant
month effeet PHA (Γ=2 27, /> = 0 017, df= 10,145), PWM
( λ = 2 3 6 , P = ÜO13, df= 10,145), Con A 10 figß (Γ=3 10,
P = 0 003, df= 10,145) and Con Α 40/ig/1 ( F = 3 91 /> = 0 000,
df= 10,145) (Tablc 2) The month-effea was found foi PHA in
April and November, (oi PWM in October and Novcmbci foi
Con Α 10 in August, Novcmbci and Dcccmbci and foi Con Α
40 in April, August, November and Dccembei (Table 3)
The icsults fot the pumaiy MLC wcic inconsistenl Ol the
thicc pools tested, only MLC-1, but not MLC 2 and MLC-3
was observed to have a signiheant month-effeet (Γ= 3 74,
/' = () 000, df= 10,155) (Table 2) Companson of HLA hcquen-
cies in the thiee pools did not leveal any diffeiences which could
cxplain this inconsistency Ilowcvei the slandaid dcviation ol
the tnpheates was quite often above 25% (in 40'/ of the
obsei vaüons) 1 Ins was twicc as often the ease foi pool 1 as foi
pool 2 and 3 Α possible cxplanaticn foi this lattei hnding could
bc that the toutinc plating of th s pool, ι e the hrsl row of a
miciotiirc test plate, has !ed to ι systcmalic cnoi
No significant month-effec1 was observed on cytotoxic Τ cell
alloi eactivily measured against any of the thrce stimulator pools
used (Tablc 2)
DISCUSSiON
Fwo souices of vanance aie descnbed which ll they aic not
aecounted foi, can scnously intcifcic with a reliable inteipicta-
tion of the icsults of immunological follow up sludics The
between-Stibjcct vanabihty aecounts in oui study Ioi about
70'/) ot the total vanancc Sincc the betwcen-subject-cffcct IS so
dominant, lt implies lhat vciy laige sample sizes aie needcd to
find significant diffeienccs between gioups if only a Single
observation pei individual is available Howevci if the same
gioup of subjeets is lcpcatcdly, and piefciably moic than twicc
measuied for the samc immunological paiametcis then the
bctwecn-subjcct vanabihty is easily taken into aecount and
othei souices of vanation including that which is lelated to
month of-data-samphng, can bc estimated with gicatci aecu-
lacy In oui study the slandaid enoi ol the month-specihc
valucs was in this way dccicascd by a factoi of about 2
The vanabihty in immunological in utio data which IS
ι elated to the month of-data-samphng is less easily estabhshed
in an intci vention study It is impossible to estimatc the month-
effeet independent ol the mteivcntion-cffcct if the intet vention
oi Ucalment is lmplcmcntcd on a speeihe datc oi in a speeihe
month Howevci, if a contiol gioup is tested in paiallcl lo the
expcnmcntal gioup then the lesults of the contiol gioup can be
used to eslimate the monlh-ielated vanabihty In an ongomg
longitudmal study hkc ouis in which the datc of intci vention
vaues the month-effeet can also be estabhshed An equal
dislnbution oi dato of intci vention ovci the months of the yeai
wouid be the most complcte and giaccful design, icsulting in the
most aecurate estimation ol the month-efleet and theicfoic also
in the most accuiatc cstimalion ol the intcivcntion-cffect The
possibihty ol laully conclusions li the month-ι elated vanability
is not taken into aecount can best be demonstrated with an
cxamplc If, in om study, the peicentage οι CD4 ceüs was
assessed pic-ticatment in May and the post-tieatment data wcie
collccted in Octobei and Novcmbci then a signiheant effeet
would have becn observed (Tablc 3) This significant effeet
would, in the absence of a contiol gioup bc altr.butcd to the
ticatment When the monlh-iclated vanability is taken into
aecount it becomes evident that the obseivcd significant effeet
can bc as well oi bcttci aecounted foi by the month ι elated
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vanabihty Special attention IS thcrefore needed when, in
follow-up studies, immunological assays are used for which
sigmficdnt month-effects have been obscrved
We observed month-eflecls for MCH and MCHC, the
percentage of CD4 and CD8 cells and for the prohferative
response to PHA, PWM and Con Α These results confirm and
extend previous results by others who observed a month-effect
for MCH and MCHC (Rocker et al, 1980), for the number of
leukocytes, Τ cells and Β cells (Bratescu & Teodorescu, 1981,
MacMurray et al, 1983), for the prohferative response to
mitogens (Boctor et al, 1989) and for serum concentrations of
IgG (Lyngbye & Kroll, 1971, MacMurray et al, 1983)
These results cannot be used to correct results of the same
immunological assays obtained in another year oi chmatologi-
cal area However, the statistical method presented can be of use
for others since lt allows the estimation of the month-efTect in a
rchable way, ι e after takmg the between-subjeet-effeet into
aecount Inference about the statistical sigmhcance of the eifert
of the Intervention can be denved from the companson of the I-
values of month-effect and intervention-effect An important
advantage of the presented method is that lt can casily be
applied in different kinds of immunological follow-up studies
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